Axon Enterprise (NASDAQ:AXON – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Tuesday, August 6th. Analysts expect Axon Enterprise to post earnings of $1.06 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. The firm had revenue of $460.74 million for the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The firm’s revenue was up 34.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.51 EPS. On average, analysts expect Axon Enterprise to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Axon Enterprise Price Performance
Shares of NASDAQ AXON opened at $292.36 on Friday. The stock has a market cap of $22.06 billion, a price-to-earnings ratio of 85.49, a PEG ratio of 6.75 and a beta of 0.95. Axon Enterprise has a 52 week low of $175.37 and a 52 week high of $329.87. The company’s 50-day moving average price is $296.00 and its 200 day moving average price is $293.82. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37.
Analyst Ratings Changes
A number of equities research analysts recently commented on AXON shares. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Jefferies Financial Group initiated coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective on the stock. JPMorgan Chase & Co. raised their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. Morgan Stanley raised their price target on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, April 26th. Finally, Bank of America initiated coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $380.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $342.54.
View Our Latest Stock Analysis on AXON
Insider Buying and Selling
In related news, Director Julie A. Cullivan sold 993 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $281.72, for a total value of $279,747.96. Following the sale, the director now directly owns 4,553 shares of the company’s stock, valued at $1,282,671.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Julie A. Cullivan sold 993 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $281.72, for a total value of $279,747.96. Following the transaction, the director now owns 4,553 shares in the company, valued at $1,282,671.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey C. Kunins sold 43,668 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the completion of the transaction, the insider now owns 189,719 shares in the company, valued at approximately $58,801,506.86. The disclosure for this sale can be found here. Over the last three months, insiders have sold 89,447 shares of company stock valued at $27,684,677. Insiders own 6.10% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.
